The University of Strathclyde, Glasgow is inviting applications for the MSc Advanced Biochemistry course starting in September 2021

MSc Advanced Biochemistry course

The University of Strathclyde, Glasgow  is inviting applications for the MSc Advanced Biochemistry course starting in September 2021.

Studying an MSc in Advanced Biochemistry at the University of Strathclyde, you’ll learn at Strathclyde Institute of Pharmacy & Biomedical Sciences. A leading centre for research, the Institute is focused on developing new medicines, better medicines and better use of medicines.

Advanced Biochemistry has a special focus on how cells work at molecular level. Together with the related field of molecular biology, biochemistry provides important advances in understanding the molecular basis of life, and how alteration or disruption of these molecular pathways leads to disease processes.

The Masters in Advanced Biochemistry will provide you with comprehensive postgraduate life sciences training. You’ll receive dedicated training in a broad range of practical laboratory skills. This is complemented by classes that develop your transferable skills in: statistics, presentations, career development, ethics, science writing skills, your ability to design experiments and analyse sophisticated datasets

The taught classes capture the excitement of cutting-edge research fields. You’ll be taught by active researchers or practising clinical professionals.

You’ll have two semesters of postgraduate laboratories. You’ll attend short optional classes in:in vivo biology, drug discovery, haematology

You’ll also choose two classes from the following: clinical biochemistry, applied biochemistry

Finally, you’ll undertake a summer project in an active research laboratory.

Eligibility- Minimum second-class honours degree or international equivalent in a biological or chemical discipline. Minimum score of IELTS 6.0 (with no component below 5.5).

Fee- £20,650 for international students for 2021/22.

For further information – or contact:

Comments are closed.